AP - Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.
AP - It's hard to predict which pills will best lower which patient's high blood pressure, but researchers are hunting ways to better personalize therapy — perhaps even using a blood test.